Home / News & Videos / News / Press Releases /

BGU Researchers Reveal Connection Between Cancer and Human Evolution

BGU Researchers Reveal Connection Between Cancer and Human Evolution

July 2, 2009

Press Releases

BEER-SHEVA, ISRAEL — July 2, 2009 — Researchers at Ben-Gurion University of the Negev (BGU) have discovered that gene mutations that once helped humans survive may increase the possibility for diseases, including cancer.


The findings were recently the cover story in the journal Genome Research.

The team of researchers from BGU’s National Institute for Biotechnology in the Negev (NIBN) set out to look for mutations in the genome of the mitochondria, a part of every cell responsible for energy production that is passed exclusively from mothers to their children.

The mitochondria are essential to every cell’s survival and our ability to perform the functions of living.

“Our ancestors responded to environmental changes, such as climate shift, with mutations that increased their chances of survival. But today, these same mutations predispose us toward complex diseases such as cancer,” according to researcher Dr. Dan Mishmar, a molecular biologist from the Department of Life Sciences at BGU.

“Although mitochondria’s role in the emergence of new species has been investigated recently, the idea that they are responsible for our susceptibility to illness startles many.”


To test this hypothesis, the researchers analyzed the genome mitochondria mutations from 98 unrelated individuals.

Combinations of mutations tended to occur in tumors in precisely the same DNA building blocks that changed during evolution. The team also found that the mitochondrial genome of humans who migrated out of Africa to Europe 100,000 years ago carried seven mutations found in almost all of today’s Europeans.
 
“The concept that the same principles that drive evolution toward the emergence of new species govern the emergence of diseases is new,” Mishmar explains.

“A clinician looks at the genome of a tumor, or other disease, and compares it to the normal population, looking for new mutations that do not occur there.  

“I assume the mutations are already part of the population and have had a survival function. When these same mutations reoccur in the correct environment, they can cause disease.”

As reported in the leading journal Genome Research, “We show, strikingly, that evolution repeated itself in cancer. If we better understand how evolution moved, we can understand the genetic basis of many complex disorders.

“Since mitochondria play a central role in disease, if we understand how they work and the way they changed our ability to survive in different conditions in ancient times, we can understand the mechanics of the disease.

“And we’ll understand a lot about the way certain people develop diseases and others have a lower tendency toward those same diseases. This may lead to new methods of disease prevention or cures.”

Along with Dr. Mishmar whose background as an archaeologist is evident in his current medical research, the research team consisted of Dr. Eitan Rubin, from the Department of Microbiology and Immunology, and graduate students Ilia Zhidkov and Erez A. Livneh. 

About American Associates, Ben-Gurion University of the Negev

American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion’s vision: creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University’s expertise locally and around the globe. As Ben-Gurion University of the Negev (BGU) celebrates its 50th birthday this year, AABGU imagines a future that goes beyond the walls of academia. It is a future where BGU invents a new world and inspires a vision for a stronger Israel and its next generation of leaders. Together with supporters, AABGU will help the University foster excellence in teaching, research and outreach to the communities of the Negev for the next 50 years and beyond.

Media Contact:
Andrew Lavin
A. Lavin Communications
516-944-4486
alc@alavin.com